MDM2 and neoplasm: Overexpression of Mdm4 in tumours has been demonstrated to compromise the efficiency of Mdm2 specific compounds, presumably through the maintenance of heterodimeric complexes of Mdm2 and Mdm4 that inhibit and target p53 for proteosomal degradation36.